Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Intensity Therapeutics Inc. (INTS) had Income from Continuous Operations of $-2.54M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-2.54M |
|
-- |
|
-- |
|
$2.71M |
|
$-2.71M |
|
$0.17M |
|
$-2.54M |
|
$-2.54M |
|
$-2.54M |
|
Income from Continuous Operations |
$-2.54M |
$-2.54M |
|
$-2.54M |
|
$-2.71M |
|
$-2.70M |
|
18.87M |
|
18.87M |
|
$-0.13 |
|
$-0.13 |
|
Balance Sheet Financials | |
$3.04M |
|
-- |
|
$1.41M |
|
$4.44M |
|
$2.16M |
|
$0.10M |
|
$0.10M |
|
$2.26M |
|
$2.18M |
|
$2.18M |
|
$2.18M |
|
26.17M |
|
Cash Flow Statement Financials | |
$-4.45M |
|
-- |
|
$4.07M |
|
$2.59M |
|
$2.22M |
|
$-0.37M |
|
$1.08M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.40 |
|
-- |
|
-- |
|
0.04 |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-116.16% |
|
-116.16% |
|
-57.10% |
|
-111.32% |
|
$0.08 |
|
$-0.24 |
|
$-0.24 |